Brief reportBidirectionally Adjustable TIPS Reduction by Parallel Stent and Stent-Graft Deployment
Section snippets
Materials and Methods
Patient data were handled in accordance with the Health Insurance Portability and Accountability Act. The institutional review board granted exemption from obtaining consent for this retrospective report.
Results
The TIPS reduction procedure was successfully performed in all six cases (ie, 100% technical success rate), reestablishing venographically evident hepatopetal flow in intrahepatic portal veins. The portosystemic gradient was increased by a mean and median of 8 mm Hg (Table 1), for a final gradient (mean and median) of 17 mm Hg (range 10–20 mm Hg). All devices tested functioned adequately, and length of bare stent did not appear to affect function. Subtle differences between stent-graft designs
Discussion
Multiple methods of TIPS reduction have previously been described and reviewed (6). Flow lumen reduction with the use of covered stents rather than bare stents offers the advantage of a more predictable and immediate effect on the flow dynamics through the TIPS. However, most techniques described have the limitation that, after the stent-graft is deployed, the diameter of the waist cannot be adjusted, particularly in the direction of further flow reduction. To address this issue, we developed
References (14)
- et al.
American Association for the Study of Liver Diseases Practice Guidelines: the role of transjugular intrahepatic portosystemic shunt creation in the management of portal hypertension
J Vasc Interv Radiol
(2005) - et al.
Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients
Gastroenterology
(1995) - et al.
Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal hemorrhage
J Hepatol
(1995) - et al.
Fatal hemodynamic consequences of therapeutic closure of a transjugular intrahepatic portosystemic shunt
J Vasc Interv Radiol
(1994) - et al.
TIPS reduction with use of stents or stent-grafts
J Vasc Interv Radiol
(2004) - et al.
A technique for controlled partial closure of a transjugular intrahepatic portosystemic shunt tract in a patient with hepatic encephalopathy
J Vasc Interv Radiol
(2006) - et al.
High occlusion rate in experimental transjugular intrahepatic portosystemic shunt created with a Dacron-covered nitinol stent
J Vasc Interv Radiol
(1999)
Cited by (35)
Occult Portoenteric Fistula after Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation in a Transplanted Liver
2024, Journal of Vascular and Interventional RadiologyClinical Outcomes and Patency after Transjugular Intrahepatic Portosystemic Shunt Reduction for Overshunting Adverse Events
2022, Journal of Vascular and Interventional RadiologyCoaxial Stent Graft inside a Constraining Stent for Transjugular Intrahepatic Portosystemic Shunt Reduction
2022, Journal of Vascular and Interventional RadiologyPercutaneous shunt reduction for the management of TIPS-induced acute liver decompensation: A follow-up study
2016, Annals of HepatologyCitation Excerpt :The rationale of TIPS reduction is to narrow the shunt flow lumen while preserving its patency, thereby increasing portal blood perfusion of the liver. The technique of TIPS reduction is the same as described for the interventional radiological management of TIPS-induced hepatic encephalopathy.7 –10 The purpose of this study was to characterise the technical, haemodynamic, laboratory and clinical outcomes of TIPS reduction in the treatment of TIPS-induced acute liver decompensation.
Techniques for Transjugular Intrahepatic Portosystemic Shunt Reduction and Occlusion
2016, Techniques in Vascular and Interventional RadiologyCitation Excerpt :Its diameter should match the diameter of the existing TIPS shunt, which in most cases is 10 mm. Sze et al14 have advocated utilization of the PTE-covered Wallgraft (Boston Scientific) as the stent compresses in a cylindrical manner, compared with a variety of polytetrafluoroethylene (PTFE)-covered stent grafts (Viabahn & Viatorr; WL Gore / Non-Flair Flair; Bard) that tend to assume nonsymmetrical shapes with adjacent compression. The principal objection to using the Wallgraft is diminished patency compared to PTFE-covered stents.
Long-Term Patency and Clinical Analysis of Expanded Polytetrafluoroethylene-Covered Transjugular Intrahepatic Portosystemic Shunt Stent Grafts
2015, Journal of Vascular and Interventional Radiology
From the SIR 2007 Annual Meeting.
D.Y.S. is a paid consultant to MediGene, Inc. (San Diego, California), Jennerex Biotherapeutics, Inc. (San Francisco, California), and Pain Therapeutics, Inc (San Mateo, California). None of the authors have identified a conflict of interest.